In February 2026, Sava Technologies reported early clinical results for a microsensor-based continuous glucose monitor (CGM) involving 46 participants with diabetes, showing reliable measurements over 10 days.1
Washington State University developed a wearable biosensor using microneedles and signal amplification to minimize skin discomfort; the team filed a provisional patent and is advancing to preclinical testing.1
The EU-backed H2TRAIN project is developing sweat biosensors using graphene oxide, integrated with edge-cloud AI for biomarker analysis like lactate, cortisol, and C-reactive protein.1
Smart contact lenses in 2026 enable non-invasive tear biomarker analysis for glucose and systemic health, building on 2024 research in Nature Communications.12
Wearable biosensors market is projected to grow from USD 29.6 billion in 2023 to USD 65.4 billion by 2033 at a CAGR of 8.2%, driven by real-time health monitoring.4
Biosensors market expected to expand from USD 35.46 billion in 2026 to USD 74.76 billion by 2035 at a CAGR of 8.64%, with advancements in miniaturization and non-invasive tracking.5
Sources:
1. https://www.azosensors.com/article.aspx?ArticleID=3282
2. https://vertu.com/guides/top-7-wearable-biosensor-innovations-revolutionizing-healthcare-in-2026/
4. https://www.openpr.com/news/4375754/leading-companies-fueling-innovation-and-growth-in-the-wearable
5. https://www.towardshealthcare.com/insights/biosensors-market-sizing